Rossari Biotech Ltd
Rossari Biotech Ltd (ROSSARI) last traded at ₹499, a market capitalisation of ₹2,765 crore, on a P/E of 18.3. Over the past 52 weeks the stock has ranged between ₹373 and ₹691. Rossari Biotech Ltd last reported results for the quarter ended Jun 2026, with sales of ₹697 crore and net profit of ₹35 crore. Figures are as of 24 Aug 2026 and are not real time.
Rossari Biotech Ltd share price and key metrics
Metrics as of 24 Aug 2026. Not real time.
Rossari Biotech Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹697 cr, up 28.1% from ₹544 cr a year earlier. Net profit was ₹35 cr, up 2.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 498 | 513 | 580 | 544 | 586 | 582 | 685 | 697 |
| Expenses | 432 | 448 | 510 | 476 | 514 | 513 | 608 | 617 |
| Operating profit | 66 | 65 | 69 | 68 | 72 | 69 | 77 | 81 |
| OPM % | 13% | 13% | 12% | 12% | 12% | 12% | 11% | 12% |
| Other income | 1 | 1 | 2 | 2 | 2 | 1 | 20 | 4 |
| Interest | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 |
| Depreciation | 15 | 18 | 18 | 18 | 18 | 20 | 24 | 26 |
| Profit before tax | 48 | 42 | 48 | 46 | 50 | 43 | 64 | 48 |
| Tax % | 27% | 25% | 28% | 27% | 26% | 23% | 28% | 26% |
| Net profit | 35 | 32 | 34 | 34 | 37 | 33 | 46 | 35 |
| EPS (₹) | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 | 6.34 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Rossari Biotech Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 | 2,550 |
| Operating profit | 124 | 184 | 223 | 250 | 265 | 286 | 299 |
| OPM % | 17% | 12% | 13% | 14% | 13% | 12% | 12% |
| Net profit | 80 | 98 | 107 | 131 | 136 | 149 | 151 |
| EPS (₹) | 15.45 | 17.74 | 19.45 | 23.66 | 24.63 | 26.94 | 27.22 |
TTM is the trailing twelve months to the most recent quarter.
Rossari Biotech Ltd growth and returns
- 10 Years
- %
- 5 Years
- 28%
- 3 Years
- 13%
- TTM
- 19%
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- 8%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- -18%
- 3 Years
- -15%
- 1 Year
- -21%
- 10 Years
- %
- 5 Years
- 13%
- 3 Years
- 12%
- Last Year
- 11%
Rossari Biotech Ltd shareholding pattern
Promoters held 68.14% at Jun 2026, broadly unchanged since Jun 2025. FIIs 2.03% and DIIs 14.64%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 68.27% | 68.19% | 68.18% | 68.18% | 68.18% | 68.15% | 68.15% | 68.14% |
| FIIs | 3.74% | 3.74% | 3.98% | 3.48% | 2.70% | 2.32% | 2.18% | 2.03% |
| DIIs | 17.34% | 17.47% | 17.59% | 17.84% | 18.18% | 18.25% | 18.21% | 14.64% |
| Public | 10.64% | 10.60% | 10.24% | 10.50% | 10.95% | 11.25% | 11.46% | 15.19% |
| No. of shareholders | 97,188 | 95,735 | 92,852 | 91,791 | 91,387 | 89,249 | 86,972 | 87,580 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Rossari Biotech Ltd corporate filings
- Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.Company Updatelow impact
Cruxal's analysis: Rossari Biotech has formally intimated that it will not participate in the investors and…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Rossari Biotech Ltd
Cruxal reads every Rossari Biotech Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.